Eight members of the CNBC IQ 100 Index hit all-time or multi-year highs today February 16, 2017.
U.S. equities traded mixed as investors continued to evaluate the latest policies from the White House.
Stocks notched their worst day of 2017, as a new measure taken by the Trump administration on immigration sent jitters through the market.
Markets will be busy with economic reports and earnings, but Washington could continue to dominate.
Mark Luschini, Janney Montgomery Scott, and Chris Cordaro, RegentAtlantic Capital CIO, share their stock picks amid all-time highs in the market.
U.S. stock index futures pointed to a slightly higher open on Tuesday, as investors prepared themselves for a deluge of earnings and data.
Is the market about to go on another bull run, or is it all a head fake? With Robert Luna, Surevest Wealth Management, and Mark Lehmann, JMP securities.
Carter Worth, Cornerstone Macro, looks at bargains in the current post-Brexit market climate, with the "Fast Money" traders.
Check out the companies making headlines after the bell Tuesday: HP Enterprise, Intuit and more.
“Mad Money” host Jim Cramer’s dishing out the impact he thinks a Trump nomination could have on top stocks.
Mark Newton, chief technical analyst at Greywolf Execution Partners, shares his top investment idea for the months ahead.
Mark Newton, chief technical analyst at Greywolf Execution Partners, shares his top trade ahead of the Fed's looming rate hike.
Travelers reported a stronger-than-expected profit as catastrophe losses almost halved and it recorded a gain from the resolution of tax issues.
CNBC Pro highlights the top performing stocks this week and analyzes whether the good times will continue.
Jim Cramer sees a lot of good news out there, but it's taking a backseat to trouble overseas.
The "Halftime Report" traders give their trades for the rest of the week
Mark Dwelle, RBC Capital Markets analyst, weighs in on ACE's cash and stock acquisition of rival insurance giant Chubb.
Ace Ltd. is buying Chubb Corp. for a total value of $124 a share.
Some of the names on the move ahead of the open.
A big name insurer is warning of possible Ebola-related restrictions on business liability coverage.